🇺🇸 FDA
Pipeline program

HEC96719

HEC96719-NASH-201

Phase 2 small_molecule completed

Quick answer

HEC96719 for Non-Alcoholic Steatohepatitis is a Phase 2 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Non-Alcoholic Steatohepatitis
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials